within Pharmacolibrary.Drugs.ATC.R;

model R03DA02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 6.666666666666667e-07,
    adminDuration  = 600,
    adminMass      = 200 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.004166666666666667,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R03DA02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Choline theophyllinate is a salt formed from the combination of theophylline, a methylxanthine bronchodilator, and choline, a B-complex vitamin. It was used as a bronchodilator in the management of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD), but is largely obsolete today and rarely used in modern clinical practice.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for oral administration, healthy adults. No published pharmacokinetic studies specifically for choline theophyllinate found; values are estimated based on published parameters of theophylline.</p><h4>References</h4><ol><li><p>Hibberd, SG, et al., &amp; Holgate, ST (1986). Acute and chronic pharmacokinetics of asymmetrical doses of slow release choline theophyllinate in asthma. <i>British journal of clinical pharmacology</i> 22(3) 337–341. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1986.tb02896.x&quot;>10.1111/j.1365-2125.1986.tb02896.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3768245/&quot;>https://pubmed.ncbi.nlm.nih.gov/3768245</a></p></li><li><p>Helms, P, et al., &amp; Wilson, R (1983). A comparative trial of choline theophyllinate and controlled release aminophylline in chronic childhood asthma. <i>European journal of pediatrics</i> 141(2) 89–91. DOI:<a href=&quot;https://doi.org/10.1007/BF00496796&quot;>10.1007/BF00496796</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6662147/&quot;>https://pubmed.ncbi.nlm.nih.gov/6662147</a></p></li><li><p>Svedmyr, K, et al., &amp; Svedmyr, N (1982). Bioavailability of theophylline from three different tablets in asthmatic patients and their bronchodilating effects in combination with terbutaline inhalation. <i>Allergy</i> 37(2) 111–117. DOI:<a href=&quot;https://doi.org/10.1111/j.1398-9995.1982.tb01884.x&quot;>10.1111/j.1398-9995.1982.tb01884.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7137520/&quot;>https://pubmed.ncbi.nlm.nih.gov/7137520</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R03DA02;
